Atrial Flutter
Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).
Drugs by status
Approved for this indication (2)
Phase 4 trials (16)
Phase 3 trials (13)
Phase 2 trials (6)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (14)
- Biotronik, Inc.
- Boehringer Ingelheim
- CAMC Health System
- Diakonhjemmet Hospital
- German Atrial Fibrillation Network
- Maimonides Medical Center
- Melbourne Health
- Wake Forest University
- West Virginia University
- Vanderbilt University
- Icahn School of Medicine at Mount Sinai
- Thoracic & Cardiovascular Healthcare Foundation, Lansing, MI
- Johannes Gutenburg University
- Mercy Health Muskegon
Organization Involved with Phase 3 Indications (25)
- Bristol-Myers Squibb
- Astellas
- Sanofi
- ARYx Therapeutics
- Bayer
- Cardiome Pharma
- Hamilton Health Sciences Corporation
- Solvay
- The Hospital for Sick Children
- Academia Sinica, Taiwan
- Chang Gung University
- University of London
- Kaohsiung Medical University
- McMaster University
- NHS Lothian
- Tufts University
- University of Edinburgh
- University of Toronto
- Institute of Biomedical Sciences, Academia Sinica
- University of Lyon
- Canadian Institutes of Health Research (CIHR)
- LivaNova
- Johnson and Johnson
- China Medical University
- Government of France
Organization Involved with Phase 2 Indications (9)